Katsunori Asai

Phase I/II study of tirabrutinib, a second-generation Bruton’s tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma

Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima et al. · Neuro-Oncology · 2020 · 170 citations · Full text

Dysbiosis of Gut Microbiome Is Associated With Rupture of Cerebral Aneurysms

Shuhei Kawabata, Masatoshi Takagaki, Hajime Nakamura et al. · Stroke · 2021 · 51 citations · Full text

Effect of coil packing proximal to the dilated segment on postoperative medullary infarction and prognosis following internal trapping for ruptured vertebral artery dissection

Hiroyuki Ikeda, Hirotoshi Imamura, Yohei Mineharu et al. · Interventional Neuroradiology · 2015 · 23 citations

Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial

Yoshitaka Narita, Yoshihiro Muragaki, Naoki Kagawa et al. · Cancer Science · 2021 · 22 citations · Full text

World Health Organization, Pharmacotherapy, High-grade Gliomas +19

Third Dentition Is the Main Cause of Premolar Supernumerary Tooth Formation

Honoka Kiso, Katsu Takahashi, S. Mishima et al. · Journal of Dental Research · 2019 · 21 citations · Full text